In vitro experiments demonstrated that E2F7 inhibition suppressed cancer cell proliferation and minimized the 50% inhibitory concentration of S-1.<h4>Conclusions</h4>Tissue mRNA expression levels of E2F7 correlated with patient prognosis in PC. Here, E2F7 is linked to pachyonychia congenita.